Apolipoprotein-e genotyping in alzheimer’s disease and frontotemporal dementia

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 4, 1997, Pages 240-243

  Gustafson, Lars ^a   Abrahamson, Magnus ^a   Grubb, Anders ^a   Nilsson, Karin ^a   Fex, Göran ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer s disease; Apolipoprotein E; Frontotemporal dementia; Isoforms

Indexed keywords

AMYLOID; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CHROMOSOME 19; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RISK; SENILE PLAQUE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DEMENTIA; DNA; FEMALE; FRONTAL LOBE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; TEMPORAL LOBE;

EID: 0030920510     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106637     Document Type: Article

References (30)

1. Brun A, Gustafson L: I. The Lund longitudinal dementia study: A 25-year perspective on neuropathology. differential diagnosis and treatment; in Nicolini M. Corain B. Winblad B, Wisniewski H. Zatta P (eds): Wiley, New York. 1993. pp 4-18.
2. Gustafson L: Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987:6: 209-223.
3. Neary D. Snowden JS. Northern V. Goulding P: Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988:51:353-361.
4. Brun A, Englund E. Gustafson L. Passant U, Mann DMA, Neary D, Snowden JS: Consensus statement - clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg & Psychiatry 1994;57:416-418.
5. Brun A, Gustafson L: Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr 1976;223:15-33.
6. Brun A: Frontal lobe degeneration of non-Alzheimer type revisited. Dementia 1993:4:126-131.
7. Constantinidis J. Richard J. Tissot R: Pick’s disease. Histological and clinical correlations. Eur Neurol 1974;57:208-217.
8. Levy Lahad E, Wasco W. Poorkay P. Romano DM, Oshima J. Pettingell WH. Yu CE. Jondro PD, Schmidt SD. Wang K. Crowley AC, Fu YH, Guenette SY. Galas D. Nemens E. Wijsman EM. Bird TD. Schellenberg GD. Tanzi RE: A familial Alzheimer's disease locus on chromosome I. Science 1995;269:973-977.
9. Schellenberg GD, Bird TD. Wijsman EM, Orr HT, Anderson L, Nemens E. White JA. Bonny-castle L, Weber JL, Alonso ME, Potter H. Heston LL. Martin GM: Genetic linkage evidence for familial Alzheimer’s disease locus on chromosome 14. Science 1992:258:668-671.
10. Goate A. Chartier-Harlin M-C. Mullen M, Brown J, Crawford F, Fidani L. Giuffra L. Haynes A. Irving N, James L, Mam R, Newton P, Rooke K. Roques P. Talbot C, Pericak-Vances M, Roses A, Williamson R. Rossor M. Owen M, Hardy J: Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
11. Lannfelt L, Bogdanovic N. Appelgren H. Axelman K, Lilius L. Hansson G. Schenk D. Hardy J, Winblad B: Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 1994,168:254-256.
12. Gydesen S, Hagen S, Klinken L. Abelskov J. Sorensc SA: Acta Psychiatr Scand 1994:176: 45-46.
13. Wilhelmsen KC, Lynch T, Pavlou E. Higgins M, Nygaard TG: Localization of disinhibition-dementia. Parkinsonism. Amyotrophy-complex (DDPAC) to 17q21-22. Am J Hum Genet 1994:55:1159-1165.
14. Stevens M. von Swieten JC. Niermeijer MF. Tibben A, Oostra BA, Heutink P: Frontal lobe dementia: Linkage to chromosome 17 in two large Dutch families. Neurobiol Aging 1996; 17(suppl 4):S186.
15. Poirier J. Davignon J. Bouthillier D. Kogan S. Bertrand P. Gauthier S: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993:342:697-699.
16. Saunders AM, Strittmatter WJ. Schmechel D. St George-Hyslop P. Pericak-Vance MA. Joo SH. Rosi BL, Gusella JF. Crapper-MacLack-Ian DR. Alberts MJ, Hulette C. Crain B. Goldgaber D, Roses AD: Association of apolipoprotein E allele c4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
17. Corder EH. Saunders AM. Strittmatter WJ. Schmechel DE. Gasakell PS. Small GW. Roses AD, Haines JL. Pericak-Vance MA: Gene dose of apoliprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993:261:921-923.
18. Schmechel DE. Saunders AM, Strittmatter WJ. Crain BJ, Hulette CM. Joo SH. Pericak-Vancc MA. Goldgaber D. Roses AD: Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onsct Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649-9653.
19. Soininen H. Kosunen O. Helisalmi S, Mannermaa A. Paljarvi L, Talasniemi S. Ryynancn M, Riekkincn PSr: A severe loss of choline acetyl-transferase in the front cortex of Alzheimer patients carrying apoliprotein 4 allele. Neurosci Lett 1995;187:79-82.
20. Frisoni GB. Calabresi L, Geroldi C. Bianchetti A, D’Acquarica AL, Govoni S. Sirtori CR. Trabucchi M. Franceschini G: Apolipoprotein E ε4 allele in Alzheimer’s disease and vascular dementia. Dementia 1994;5:240-242.
21. Amouyel P. Vidal O. Launay JM. Laplanche JL: The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994:344:1315-1318.
22. St Claire D. Norrman J. Perry RH Yates C. Wilcock G. Brookes A: Apolipoprotein E e4 allele frequency in Lewy body dementia. Alzheimer’s disease and age matched controls. Neurosci Lett 1994:176:45-46.
23. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. ed3. rev. Washington. American Psychiatric Association. 1987.
24. McKhann G. Drachman D. Folslein M, Katz-man R. Price D. Standlan E: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984:34:939-944.
25. Risberg J. Passant U. Warkentin S. Gustafson L: Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer’s type. Dementia 1993;4:186-187.
26. Miller SA. Dykes DD. Polesky HF: A simple salting out procedere for extracting DNA from human nucleated cells. Nucleic Acids Res 1988:16:1215.
27. Kontula K. Aalto-Setälä K. Kuusi T. Hämäläinen L. Syvänen A-C: Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: Convenient alternative to phenotyping by isoelectric focusing. Clin Chem 1990:36:2087-2092.
28. Pickering-Brown SM, Siddons N, Mann DMA, Owen F, Nceary D, Snowden JS: Apolipoprotein e allelic frequencies in patients with lobar atrophy. Neurosci Lett 1995;188:205-207.
29. Lehtovirta M. Soininen H, Laakso MP. Partanen K. Helisalmi S. Mannemiaa A. Ryynanen M, Kuikka J. Hartikainen P. Riekkincn PJ Sr: SPECT and MRI analysis in Alzheimer’s disease: Relation to apolipoprotein E e4 allele. J Neurol Ncurosurg Psychiatry 1996:60:644-649.
30. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994;7:180-184.